Thus, identifying new potential candidates to improve the efficacy of targeted therapies is pivotal, and the present study strengthens the translational potential of HO-1 inhibitors to improve PLX4032 efficacy both in terms of reduction of tumor cell viability and improvement of immune recognition. Here, HMOX1 is linked to neoplasm.